Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-22 · accession 0001193125-26-021378 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-23 | 2026-01-22 | AXSM | Pizzie Nick | CFO | M - OptEx | $3.50 | +12.0K | 54.6K | +28% | +$42.0K |
| DT | 2026-01-23 | 2026-01-22 | AXSM | Pizzie Nick | CFO | S - Sale+OE | $187.92 | -12.0K | 42.6K | -22% | -$2.26M |
| DT | 2026-01-23 | 2026-01-22 | AXSM | Pizzie Nick | CFO | M - OptEx | $0.00 | -12.0K | 105.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-22 | M | A | 12,000 | $3.50 | 54,588 | D | — | — | (F5) Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-01-22 | S | D | 12,000 | $187.92 | 42,588 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $185.09 and $191.12. (F5) Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-22 | M | D | 12,000 | $0.00 | 105,000 | D | $3.50 · 2019-05-16 to 2028-05-16 | 12,000 Common Stock |